ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,041 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBaselCORETAG Diagnostics AG
CORETAG Diagnostics AG Logo
Verified· 2 sources

CORETAG Diagnostics AG

Summary

About the company

CORETAG Diagnostics AG is an oncology biotechnology company developing radioligand-based diagnostic and therapeutic approaches for solid tumors. Its core work centers on the Tumor Necrosis Targeting Platform® and candidates such as CyanTag® and CyanCore® for diagnosis, therapy, and treatment response monitoring.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered5
Tumor Necrosis Targeting Platform
Proprietary platform for radioligand-based oncology, with cyanine-based targeting molecules for binding to necrotic tumor tissue and for the development of diagnostics, therapy and response monitoring.
Radioligand Diagnostics
Diagnostic radioligands for tumor necrosis, in particular NC-Scan® and CyanTag® with Copper-64 or Indium-111 for preclinical and clinical imaging.
Radioligand Therapy
Therapeutic radioligands for solid tumors, in particular CyanCore® with Lutetium-177 as well as other lead candidates such as Lead-212-based programs.
Theranostics for Solid Tumors
Theranostic development that combines diagnostics, therapy and treatment monitoring for hard-to-treat solid tumors in a radioligand-based platform.
Preclinical and IND-enabling Development
Preclinical in vitro and in vivo studies, dosimetry, biodistribution, CMC and toxicology to prepare first-in-human clinical studies.
Comparisons

CORETAG Diagnostics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank CORETAG Diagnostics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of CORETAG Diagnostics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Malzgasse 18
4052 Basel

At a glance

Legal form
Corporation
UID
CHE-469.898.968
Founded
2020 · 6 years
Last commercial register change
December 5, 2024
Employees
1 to 10

Knowledge

No knowledge articles yet

Once CORETAG Diagnostics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started

Similar companies

CT
CORETAG Therapeutics AG
Basel
CH
CORETAG Holding AG
Basel
TP
Torpedo Pharmaceuticals AG
Basel
AA
AdRegeneer AG
Basel
RI
Rocket Isotopes AG
Basel
IA
Intex-Biotech AG
Basel
DS
Dispopharm Services GmbH
Basel
EA
EsoCap AG
Basel